106 related articles for article (PubMed ID: 25441945)
41. Synthesis and Characterization of a Promising Novel FFAR1/GPR40 Targeting Fluorescent Probe for β-Cell Imaging.
Bertrand R; Wolf A; Ivashchenko Y; Löhn M; Schäfer M; Brönstrup M; Gotthardt M; Derdau V; Plettenburg O
ACS Chem Biol; 2016 Jun; 11(6):1745-54. PubMed ID: 27115176
[TBL] [Abstract][Full Text] [Related]
42. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
43. Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production.
Seto-Young D; Paliou M; Schlosser J; Avtanski D; Park A; Patel P; Holcomb K; Chang P; Poretsky L
J Clin Endocrinol Metab; 2005 Nov; 90(11):6099-105. PubMed ID: 16131582
[TBL] [Abstract][Full Text] [Related]
44. Structural insight into peroxisome proliferator-activated receptor gamma binding of two ureidofibrate-like enantiomers by molecular dynamics, cofactor interaction analysis, and site-directed mutagenesis.
Pochetti G; Mitro N; Lavecchia A; Gilardi F; Besker N; Scotti E; Aschi M; Re N; Fracchiolla G; Laghezza A; Tortorella P; Montanari R; Novellino E; Mazza F; Crestani M; Loiodice F
J Med Chem; 2010 Jun; 53(11):4354-66. PubMed ID: 20462215
[TBL] [Abstract][Full Text] [Related]
45. Ligand-induced stabilization and activation of peroxisome proliferator-activated receptor gamma.
Gani OA; Sylte I
Chem Biol Drug Des; 2008 Jul; 72(1):50-7. PubMed ID: 18554251
[TBL] [Abstract][Full Text] [Related]
46. Toward molecular imaging of the free fatty acid receptor 1.
Hellström-Lindahl E; Åberg O; Ericsson C; O'Mahony G; Johnström P; Skrtic S; Eriksson O
Acta Diabetol; 2017 Jul; 54(7):663-668. PubMed ID: 28409274
[TBL] [Abstract][Full Text] [Related]
47. Free fatty acid receptor 1: a ray of hope in the therapy of type 2 diabetes mellitus.
Arora A; Behl T; Sehgal A; Singh S; Sharma N; Chigurupati S; Kaur R; Bhatia S; Al-Harrasi A; Vargas-De-La-Cruz C; Bungau S
Inflammopharmacology; 2021 Dec; 29(6):1625-1639. PubMed ID: 34669065
[TBL] [Abstract][Full Text] [Related]
48. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
49. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
50. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity.
Fang XK; Gao J; Zhu DN
Life Sci; 2008 Mar; 82(11-12):615-22. PubMed ID: 18262572
[TBL] [Abstract][Full Text] [Related]
51. Synthesis of N-(5-chloro-6-(quinolin-3-yloxy)pyridin-3-yl)benzenesulfonamide derivatives as non-TZD peroxisome proliferator-activated receptor γ (PPARγ) agonist.
Bajare S; Anthony J; Nair A; Marita R; Damre A; Patel D; Rao C; Sivaramakrishnan H; Deka N
Eur J Med Chem; 2012 Dec; 58():355-60. PubMed ID: 23142675
[TBL] [Abstract][Full Text] [Related]
52. 2D QSAR of PPARgamma agonist binding and transactivation.
Rücker C; Scarsi M; Meringer M
Bioorg Med Chem; 2006 Aug; 14(15):5178-95. PubMed ID: 16650995
[TBL] [Abstract][Full Text] [Related]
53. Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.
Gadhe CG; Kothandan G; Cho SJ
J Biomol Struct Dyn; 2013; 31(11):1251-76. PubMed ID: 23153179
[TBL] [Abstract][Full Text] [Related]
54. Identification of G protein-coupled receptor 120-selective agonists derived from PPARgamma agonists.
Suzuki T; Igari S; Hirasawa A; Hata M; Ishiguro M; Fujieda H; Itoh Y; Hirano T; Nakagawa H; Ogura M; Makishima M; Tsujimoto G; Miyata N
J Med Chem; 2008 Dec; 51(23):7640-4. PubMed ID: 19007110
[TBL] [Abstract][Full Text] [Related]
55. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2.
Usui S; Suzuki T; Hattori Y; Etoh K; Fujieda H; Nishizuka M; Imagawa M; Nakagawa H; Kohda K; Miyata N
Bioorg Med Chem Lett; 2005 Mar; 15(6):1547-51. PubMed ID: 15745794
[TBL] [Abstract][Full Text] [Related]
57. FFAR1/GPR40: One target, different binding sites, many agonists, no drugs, but a continuous and unprofitable tug-of-war between ligand lipophilicity, activity, and toxicity.
Governa P; Caroleo MC; Carullo G; Aiello F; Cione E; Manetti F
Bioorg Med Chem Lett; 2021 Jun; 41():127969. PubMed ID: 33771587
[TBL] [Abstract][Full Text] [Related]
58. Identification of novel G-protein-coupled receptor 40 (GPR40) agonists by hybrid
Nath V; Ahuja R; Kumar V
J Biomol Struct Dyn; 2019 Sep; 37(14):3764-3787. PubMed ID: 30252605
[TBL] [Abstract][Full Text] [Related]
59. An updated patent review of GPR40/ FFAR1 modulators (2020 - present).
Ren Q; Fan Y; Yang L; Shan M; Shi W; Qian H
Expert Opin Ther Pat; 2023; 33(9):565-577. PubMed ID: 37947382
[TBL] [Abstract][Full Text] [Related]
60. Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening.
Tikhonova IG; Sum CS; Neumann S; Engel S; Raaka BM; Costanzi S; Gershengorn MC
J Med Chem; 2008 Feb; 51(3):625-33. PubMed ID: 18193825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
